Bayesian adaptive randomization (BAR) is an attractive approach to allocate more patients to the putatively superior arm based on the interim data while maintains good statistical properties attributed to randomization. Under this approach, patients are adaptively assigned to a treatment group based on the probability that the treatment is better. The basic randomization scheme can be modified by introducing a tuning parameter, replacing the posterior estimated response probability, setting a boundary to randomization probabilities. Under randomization settings comprised of the above modifications, operating characteristics, including type I error, power, sample size, imbalance of sample size, interim success rate, and overall success rate,...
Outcome-adaptive randomization allocates more patients to the better treatments as the information a...
We propose a class of phase II clinical trial designs with sequential stopping and adaptive treatmen...
Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design f...
Bayesian adaptive randomization (BAR) is an attractive approach to allocate more patients to the put...
A response-adaptive randomization (RAR) design refers to the method in which the probability of trea...
With the increasing need for targeted agents in cancer therapies, efficient clinical trials for the ...
Monte Carlo simulation has been conducted to investigate parameter estimation and hypothesis testing...
Monte Carlo simulation has been conducted to investigate parameter estimation and hypothesis testing...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
International audienceIn controlled clinical trials, where minimizing treatment failures is crucial,...
Bayesian adaptive designs are emerging as popular approach to develop adaptive clinical trials. In t...
In a clinical trial, response-adaptive randomization (RAR) uses accumulating data to weigh the rando...
In oncology, toxicity is typically observable shortly after a chemotherapy treatment, whereas effica...
Adaptive designs for multi-armed clinical trials have become increasingly popular recently because o...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
Outcome-adaptive randomization allocates more patients to the better treatments as the information a...
We propose a class of phase II clinical trial designs with sequential stopping and adaptive treatmen...
Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design f...
Bayesian adaptive randomization (BAR) is an attractive approach to allocate more patients to the put...
A response-adaptive randomization (RAR) design refers to the method in which the probability of trea...
With the increasing need for targeted agents in cancer therapies, efficient clinical trials for the ...
Monte Carlo simulation has been conducted to investigate parameter estimation and hypothesis testing...
Monte Carlo simulation has been conducted to investigate parameter estimation and hypothesis testing...
Background Adaptive designs offer added flexibility in the execution of clinical tri...
International audienceIn controlled clinical trials, where minimizing treatment failures is crucial,...
Bayesian adaptive designs are emerging as popular approach to develop adaptive clinical trials. In t...
In a clinical trial, response-adaptive randomization (RAR) uses accumulating data to weigh the rando...
In oncology, toxicity is typically observable shortly after a chemotherapy treatment, whereas effica...
Adaptive designs for multi-armed clinical trials have become increasingly popular recently because o...
Includes bibliographical references (p. 123-128).The process of conducting a pharmaceutical clinical...
Outcome-adaptive randomization allocates more patients to the better treatments as the information a...
We propose a class of phase II clinical trial designs with sequential stopping and adaptive treatmen...
Point-of-care clinical trials are randomized clinical trials designed to maximize pragmatic design f...